News ID: 316728
Published: 0204 GMT September 29, 2021

Raeisi: Backing domestic jab producers among administration priorities

Raeisi: Backing domestic jab producers among administration priorities
Iran’s President Seyyed Ebrahim Raeisi addresses a cabinet meeting in Tehran on September 29, 2021.

National Desk

Iranian President Seyyed Ebrahim Raeisi said supporting domestic COVID-19 vaccine producers is among his administration’s priorities.

Since using foreign vaccines is faced with some limitations and cannot be permanent, today’s priority is backing domestic institutes and centers involved in developing COVID-19 jabs, he told a weekly cabinet meeting on Wednesday, IRNA reported.

He added concurrent with the increased pace of the public vaccination process, the country’s academic centers and businesses are required to gradually resume their normal activities through implementing rational measures.

Expressing satisfaction with the resumption of virtual education at Iranian schools since the beginning of the academic year (September 23), Raeisi said the ground will gradually be prepared for in-person education at the country’s academic centers following the increase in the number of the vaccinated people and alleviation of parents’ health concerns.

Iran’s public vaccination process has gained greater momentum over the past weeks in view of the rise in imports and domestic production of vaccines, setting new daily records.

The country has received several COVID-19 vaccine batches from Russia (Sputnik V), China (Sinopharm), Japan (AstraZeneca) and India (COVAXIN), and has also developed a number of COVID jabs domestically, including one dubbed COVIran Barekat (Barakat Foundation), a jab named Soberana 2, or PastoCoVac (Cuba’s Instituto Finlay de Vacunas and Iran’s Pasteur Institute) and a vaccine known as Fakhra (Defense Ministry).

The other two COVID jabs being developed in the country are Noura (the Islamic Revolution Guards Corps) and Razi Cov Pars (Razi Vaccine and Serum Research Institute).

According to figures by the Islamic Republic of Iran Customs Administration, Sinopharm accounts for the biggest share of the country’s jab purchases.


Vaccination figures


Iran’s Health Ministry announced in a statement on Wednesday that 53,809,661 COVID-19 vaccine doses have so far been administered in the country.

It added that 37,748,710 people have so far received their first dose of the vaccine, putting at 16,060,951 the number of those given a second dose.

Iran’s Health Minister Bahram Einollahi said on Tuesday that 70 percent of the country’s population will be vaccinated against COVID-19 in two weeks’ time.

Einollahi added the country will soon celebrate the victory of its vaccination campaign, IRNA reported.




The Wednesday statement by the ministry said the country’s daily COVID-19 deaths and infections reached 272 and 13,271, respectively, in the past 24 hours.

It said the total COVID-19 death toll and infections since the beginning of the outbreak in the country in late February 2020 stand at 120,160 and 5,572,962, respectively.

According to the ministry, 6,016 COVID-19 patients are in critical condition, and of the newly-detected cases, 1,891 individuals have been hospitalized.

It added that 5,009,673 COVID-19 patients have so far either recovered from the disease or have been discharged from hospitals.

The statement added 32,087,135 coronavirus diagnostic tests have so far been carried out in the country.

The Health Ministry said 29 cities in the country are coded red (very high-risk), while 224 are in the orange zone (high-risk).

The number of the country’s yellow (medium-risk) and blue (low-risk) cities are 165 and 30, respectively, according to the ministry.

Iran has been grappling with a fifth wave of the COVID-19 pandemic since a few ‎weeks ago, mainly sparked by the spread of the Indian coronavirus variant, known ‎as Delta, seeing a resurgence in deaths and infections. The number of casualties has, however, been declining since a few days ago, indicating that the country is past the peak of the fifth wave’s infections and deaths.




Resource: IRNA
Security Key:
Captcha refresh
Page Generated in 0/1438 sec